Clinical Trials Logo

Clinical Trial Summary

This trial is aimed to evaluate the safety and efficacy of DCB in treating AVF stenosis in chinese population.


Clinical Trial Description

For years, first-line treatment of AVFs stenoses has been percutaneous transluminal angioplasty. However, restenosis and reintervention rates remain incredibly high and occur, according to recent studies, in up to 60% and 70% of patients at 6 and 12 months, respectively. Drug-coated balloons delivering paclitaxel at the angioplasty site have proved their superiority in the treatment of coronary and peripheral arterial stenoses. Paclitaxel reduces neointimal hyperplasia and drug-coated balloons,therefore, it represents an attractive option for AVF stenoses. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03366727
Study type Interventional
Source Acotec Scientific Co., Ltd
Contact
Status Completed
Phase N/A
Start date May 1, 2018
Completion date July 7, 2022

See also
  Status Clinical Trial Phase
Active, not recruiting NCT06056206 - The SIR-POBA Shunt Trial N/A
Completed NCT05034939 - FLEX Vessel Prep Prior to Angioplasty in Native Arteriovenous Fistulae (AVF) N/A
Active, not recruiting NCT05545267 - Monitoring of Dialysis Vascular Accesses During Angioplasty Under Echodoppler
Recruiting NCT04543539 - IN.PACTâ„¢ AV Access Post-Approval Study (PAS002)
Completed NCT04070365 - FLEX Arteriovenous Access Registry
Not yet recruiting NCT06422845 - Peripheral Scoring Drug-coated Balloon in the Treatment of Hemodialysis Arteriovenous Fistula Stenosis N/A
Completed NCT03213756 - Isometric Preoperative Exercise on Autologous Arteriovenous Fistulas. Randomized Clinical Trial N/A
Completed NCT04312711 - 3D Time-of-Flight Magnetic Resonance Angiography in Hemodialysis Patients With Arteriovenous Fistula N/A
Completed NCT05961852 - COmbiNing Cutting and Drug-Eluting Balloon for Resistant Arteriovenous Fistula sTenOsis (CONCERTO) Phase 1
Completed NCT03041467 - IN.PACTâ„¢ AV Access IDE Study N/A